| Patent | Date |
|---|
Hydrophobic charge induction chromatographic protein depleted solution
Grant 11,426,680 - Pham , et al. August 30, 2 | 2022-08-30 |
Methods of administering inhibitory anti-factor XII/XIIa monoclonal antibodies
Grant 11,345,759 - Panousis , et al. May 31, 2 | 2022-05-31 |
Process For Purifying C1-inh
App 20210380636 - Kornilova; Anna ; et al. | 2021-12-09 |
Method Of Purifying Therapeutic Proteins
App 20210283530 - PHAM; Hung ; et al. | 2021-09-16 |
Treatment and prevention of remote ischemia-reperfusion injury
Grant 10,973,891 - Spirig , et al. April 13, 2 | 2021-04-13 |
Pharmaceutical Formulations Of C1 Esterase Inhibitor
App 20200390845 - METZNER; Hubert ; et al. | 2020-12-17 |
Methods To Reduce Adverse Events Caused By Pharmaceutical Preparations Comprising Plasma Derived Proteins
App 20200338123 - SCHULTE; Stefan ; et al. | 2020-10-29 |
Method For Virus Filtration Of Von Willebrand Factor
App 20200199176 - NOWAK; Thomas ; et al. | 2020-06-25 |
Therapy Using A Factor Xii Inhibitor In A Neurotraumatic Disorder
App 20200131248 - KLEINSCHNITZ; Christoph ; et al. | 2020-04-30 |
Combination Therapy Using A Factor Xii Inhibitor And A C-1 Inhibitor
App 20200129600 - NOLTE; Marc ; et al. | 2020-04-30 |
Proteolytically Cleavable Fusion Proteins With High Molar Specific Activity
App 20200095567 - METZNER; Hubert ; et al. | 2020-03-26 |
Methods Of Administering Inhibitory Anti-factor Xii/xiia Monoclonal Antibodies
App 20200062863 - Panousis; Con ; et al. | 2020-02-27 |
Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies
Grant 10,513,560 - Panousis , et al. Dec | 2019-12-24 |
A Blood Coagulation Factor Replacement Product For Use In The Treatment Or Prophylaxis Of Bleedings
App 20190351028 - HERZOG; Eva ; et al. | 2019-11-21 |
Combination therapy using immunoglobulin and C1-Inhibitor
Grant 10,471,142 - Basta , et al. Nov | 2019-11-12 |
Therapeutic agent for amniotic fluid embolism
Grant 10,441,631 - Kanayama , et al. Oc | 2019-10-15 |
Treatment And Prevention Of Remote Ischemia-reperfusion Injury
App 20190269766 - SPIRIG; Rolf ; et al. | 2019-09-05 |
Method Of Purifying Therapeutic Proteins
App 20190209948 - Pham; Hung ; et al. | 2019-07-11 |
Method Of Preventing Acute Attacks Of Hereditary Angioedema Associated With C1 Esterase Inhibitor Deficiency
App 20190183991 - MACHNIG; Thomas ; et al. | 2019-06-20 |
Pharmaceutical Formulations Of C1 Esterase Inhibitor
App 20190175683 - Metzner; Hubert ; et al. | 2019-06-13 |
Treatment and prevention of remote ischemia-reperfusion injury
Grant 10,286,047 - Spirig , et al. | 2019-05-14 |
Sugar compositions for treating hemophilia A and/or Von Willebrand disease
Grant 10,232,015 - Schulte , et al. | 2019-03-19 |
Hydrophobic charge induction chromatographic depletion of a protein from a solution
Grant 10,188,965 - Pham , et al. Ja | 2019-01-29 |
Factor H for the treatment of chronic nephropathies and production thereof
Grant 10,137,165 - Gronski , et al. November 27, 2 | 2018-11-27 |
Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces
Grant 9,987,328 - Zeitler , et al. June 5, 2 | 2018-06-05 |
Methods Of Administering Inhibitory Anti-factor Xii/xiia Monoclonal Antibodies
App 20180134806 - Panousis; Con ; et al. | 2018-05-17 |
Proteolytically Cleavable Fusion Proteins With High Molar Specific Activity
App 20180119128 - METZNER; Hubert ; et al. | 2018-05-03 |
Factor XII inhibitors for the treatment of neurological inflammatory disorders
Grant 9,957,329 - Meuth , et al. May 1, 2 | 2018-05-01 |
Pharmaceutical Formulations Of C1 Esterase Inhibitor
App 20180036394 - SCHAEFER; Wolfram ; et al. | 2018-02-08 |
Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies
Grant 9,856,326 - Panousis , et al. January 2, 2 | 2018-01-02 |
Nucleic acids encoding inhibitory anti-factor XII/XIIa monoclonal antibodies
Grant 9,856,325 - Panousis , et al. January 2, 2 | 2018-01-02 |
Sugar Compositions for Treating Hemophilia A and/or Von Willebrand Disease
App 20170274045 - SCHULTE; Stefan ; et al. | 2017-09-28 |
Improved Factor Viii Preparations Suitable For Therapeutic Use And Processes To Obtain These
App 20170209546 - SCHMIDBAUER; Stefan ; et al. | 2017-07-27 |
Sugar compositions for treating hemophilia A and/or von Willebrand disease
Grant 9,707,269 - Schulte , et al. July 18, 2 | 2017-07-18 |
Method Of Purifying Therapeutic Proteins
App 20170143805 - PHAM; Hung ; et al. | 2017-05-25 |
Inhibitory Anti-factor Xii/xiia Monoclonal Antibodies And Their Uses
App 20170137536 - Panousis; Con ; et al. | 2017-05-18 |
Inhibitory Anti-factor Xii/xiia Monoclonal Antibodies And Their Uses
App 20170121423 - Panousis; Con ; et al. | 2017-05-04 |
Therapy Using A Factor Xii Inhibitor In A Neurotraumatic Disorder
App 20170114119 - KLEINSCHNITZ; Christoph ; et al. | 2017-04-27 |
Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organs
Grant 9,624,307 - Nahrendorf , et al. April 18, 2 | 2017-04-18 |
MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE
App 20170080061 - WEIMER; Thomas ; et al. | 2017-03-23 |
Method of purifying therapeutic proteins
Grant 9,598,461 - Pham , et al. March 21, 2 | 2017-03-21 |
Inhibitory anti-factor XII/XIIA monoclonal antibodies and their uses
Grant 9,518,127 - Panousis , et al. December 13, 2 | 2016-12-13 |
Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving the bioavailability of factor VIII
Grant 9,511,123 - Zollner , et al. December 6, 2 | 2016-12-06 |
Holder for an injection syringe
Grant 9,474,851 - Plunnecke October 25, 2 | 2016-10-25 |
Von willebrand factor variants having improved factor VIII binding affinity
Grant 9,458,223 - Schulte , et al. October 4, 2 | 2016-10-04 |
Factor Xii Inhibitors For The Administration With Medical Procedures Comprising Contact With Artificial Surfaces
App 20160279195 - ZEITLER; Stefan ; et al. | 2016-09-29 |
Use of C1-inhibitor for the treatment of secondary edema of the central nervous system
Grant 9,452,203 - Kleinschnitz , et al. September 27, 2 | 2016-09-27 |
Use of sulfated glycosaminoglycans for improving the bioavailability of factor VIII
Grant 9,393,289 - Metzner , et al. July 19, 2 | 2016-07-19 |
Combination Therapy Using A Factor Xii Inhibitor And A C-1 Inhibitor
App 20160166660 - NOLTE; Marc ; et al. | 2016-06-16 |
Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces
Grant 9,352,016 - Zeitler , et al. May 31, 2 | 2016-05-31 |
Coagulation factor X polypeptides with modified activation properties
Grant 9,347,051 - Schulte , et al. May 24, 2 | 2016-05-24 |
Factor VIII, von Willebrand factor or complexes thereof with prolonged in vivo half-life
Grant 9,290,561 - Weimer , et al. March 22, 2 | 2016-03-22 |
Coagulation factor X polypeptides with modified activation properties
Grant 9,249,404 - Schulte , et al. February 2, 2 | 2016-02-02 |
Therapeutic Agent For Amniotic Fluid Embolism
App 20160008425 - KANAYAMA; Naohiro ; et al. | 2016-01-14 |
Treatment And Prevention Of Remote Ischemia-reperfusion Injury
App 20160008442 - SPIRIG; Rolf ; et al. | 2016-01-14 |
Proteolytically Cleavable Fusion Proteins With High Molar Specific Activity
App 20160010074 - Metzner; Hubert ; et al. | 2016-01-14 |
A Method of Purifying Therapeutic Proteins
App 20150366947 - PHAM; Hung ; et al. | 2015-12-24 |
Use of VWF stabilized FVIII preparations and of VWF preparations without FVIII for extravascular administration in the therapy and prophylactic treatment of bleeding disorders
Grant 9,107,902 - Kronthaler August 18, 2 | 2015-08-18 |
von Willebrand factor or factor VIII and von Willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes
Grant 9,095,564 - Dickneite , et al. August 4, 2 | 2015-08-04 |
Methods To Reduce Adverse Events Caused By Pharmaceutical Preparations Comprising Plasma Derived Proteins
App 20150150911 - Schulte; Stefan ; et al. | 2015-06-04 |
Sugar Compositions for Treating Hemophilia A and/or Von Willebrand Disease
App 20150087592 - Schulte; Stefan ; et al. | 2015-03-26 |
Methods for purification of alpha-1-antitrypsin and apolipoprotein A-1
Grant 8,962,802 - Brinkman , et al. February 24, 2 | 2015-02-24 |
Combined Use of a Sulfated Glycosaminoglycan and a Hyaluronidase for Improving the Bioavailability of Factor VIII
App 20150023946 - Zollner; Sabine ; et al. | 2015-01-22 |
Factor XII Inhibitors for the Treatment of Neurological Inflammatory Disorders
App 20140378653 - Meuth; Sven ; et al. | 2014-12-25 |
Use Of C1-inhibitor For The Treatment Of Secondary Edema Of The Central Nervous System
App 20140371425 - Kleinschnitz; Christoph ; et al. | 2014-12-18 |
Von Willebrand Factor Variants Having Improved Factor VIII Binding Affinity
App 20140357564 - Schulte; Stefan ; et al. | 2014-12-04 |
MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE
App 20140356346 - WEIMER; Thomas ; et al. | 2014-12-04 |
Octanoate-reduced human albumin
Grant 8,877,711 - Kiessling , et al. November 4, 2 | 2014-11-04 |
Use Of Sulfated Glycosaminoglycans For Improving The Bioavailability Of Factor Viii
App 20140315815 - Metzner; Hubert ; et al. | 2014-10-23 |
Modified Coagulation Factors With Prolonged In Vivo Half-life
App 20140273096 - SCHULTE; Stefan ; et al. | 2014-09-18 |
Modified vitamin K dependent polypeptides
Grant 8,828,939 - Weimer , et al. September 9, 2 | 2014-09-09 |
Therapeutic Polypeptides With Increased In Vivo Recovery
App 20140248686 - Weimer; Thomas ; et al. | 2014-09-04 |
Combination Therapy Using Immunoglobulin and C1-Inhibitor
App 20140234293 - Basta; Milan ; et al. | 2014-08-21 |
Modified coagulation factor VIIa with extended half-life
Grant 8,765,915 - Weimer , et al. July 1, 2 | 2014-07-01 |
Modified coagulation factors with prolonged in vivo half-life
Grant 8,754,194 - Schulte , et al. June 17, 2 | 2014-06-17 |
Von Willebrand Factor Or Factor Viii And Von Willebrand Factor For The Treatment Of Coagulopathy Induced By Inhibitors Of Thrombocytes
App 20140128325 - DICKNEITE; Gerhard ; et al. | 2014-05-08 |
Treatment of diseases linked to pathological kinin formation
Grant 8,715,672 - Nieswandt , et al. May 6, 2 | 2014-05-06 |
Methods For Purification Of Alpha-1-antitrypsin And Apolipoprotein A-1
App 20140094591 - Brinkman; Nathan ; et al. | 2014-04-03 |
Factor Viii, Von Willebrand Factor Or Complexes Thereof With Prolonged In Vivo Half-life
App 20140072561 - Weimer; Thomas ; et al. | 2014-03-13 |
Methods for purification of alpha-1-antitrypsin and apolipoprotein A-1
Grant 8,653,245 - Brinkman , et al. February 18, 2 | 2014-02-18 |
Device and method for detecting broken glass in a conveyor sterilization tunnel
Grant 8,618,464 - Hoberg December 31, 2 | 2013-12-31 |
Device and method for detecting broken glass in a conveyor sterilization tunnel
Grant 08618464 - | 2013-12-31 |
Therapeutic Polypeptides With Increased In Vivo Recovery
App 20130337532 - Weimer; Thomas ; et al. | 2013-12-19 |
von Willebrand factor or factor VIII and von Willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes
Grant 8,603,979 - Dickneite , et al. December 10, 2 | 2013-12-10 |
Synergistic therapeutic use of prothrombin complex concentrates with FVIII concentrates
Grant 8,580,737 - Dickneite November 12, 2 | 2013-11-12 |
Factor VIII, von willebrand factor or complexes thereof with prolonged in vivo half-life
Grant 8,575,104 - Weimer , et al. November 5, 2 | 2013-11-05 |
Methods For Purification Of Alpha-1-antitrypsin And Apolipoprotein A-1
App 20130289245 - Brinkman; Nathan ; et al. | 2013-10-31 |
Treatment Of Diseases Linked To Pathological Kinin Formation
App 20130164301 - NIESWANDT; Bernhard ; et al. | 2013-06-27 |
Holder For An Injection Syringe
App 20130116624 - Plunnecke; Dieter | 2013-05-09 |
Methods for purification of alpha-1-antitrypsin andapolipoprotein A-1
Grant 8,436,152 - Brinkman , et al. May 7, 2 | 2013-05-07 |
Synergistic therapeutic use of Prothrombin Complex Concentrates with FVIII concentrates
Grant 8,394,768 - Dickneite March 12, 2 | 2013-03-12 |
SYNERGISTIC THERAPEUTIC USE OF PROTHROMBIN COMPLEX CONCENTRATES WITH FVlll CONCENTRATES
App 20130005657 - DICKNEITE; Gerhard | 2013-01-03 |
Therapeutic application of Kazal-type serine protease inhibitors
Grant 8,283,319 - Schulte , et al. October 9, 2 | 2012-10-09 |
Octanoate-reduced Human Albumin
App 20120238998 - Kiessling; Peter ; et al. | 2012-09-20 |
Prevention Of Thrombus Formation And/or Stabilization
App 20120148688 - Nieswandt; Bernhard ; et al. | 2012-06-14 |
Apparatus for combining components under sterile conditions
Grant 8,172,824 - Pfeifer , et al. May 8, 2 | 2012-05-08 |
Prevention of thrombus formation and/or stabilization with inhibitors of factor XII or activated factor XII
Grant 8,119,137 - Nieswandt , et al. February 21, 2 | 2012-02-21 |
Method For The Prevention And Treatment Of Cancer By Inhibition Of Gpvi
App 20120039901 - Kronthaler; Ulrich ; et al. | 2012-02-16 |
Device for combining components by means of negative pressure under sterile conditions
Grant 8,051,884 - Reuter November 8, 2 | 2011-11-08 |
Thrombin preparations and process for their production
Grant 8,012,728 - Metzner , et al. September 6, 2 | 2011-09-06 |
Proteolytically Cleavable Fusion Proteins With High Molar Specific Activity
App 20110189182 - METZNER; Hubert ; et al. | 2011-08-04 |
Method for differentiating between factor XIII deficiency states and fibrinogen deficiency states by means of thrombelastographic techniques
Grant 7,939,288 - Wrabetz , et al. May 10, 2 | 2011-05-10 |
Proteolytically cleavable fusion proteins with high molar specific activity
Grant 7,939,632 - Metzner , et al. May 10, 2 | 2011-05-10 |
Methods For Purification Of Alpha-1-antitrypsin Andapolipoprotein A-1
App 20110087008 - Brinkman; Nathan ; et al. | 2011-04-14 |
Factor H For The Treatment Of Chronic Nephropathies And Production Thereof
App 20110046062 - Gronski; Peter ; et al. | 2011-02-24 |
Procedure for the determination of the activity of the protease which activates factor VII from protein solutions
Grant 7,892,842 - Roemisch , et al. February 22, 2 | 2011-02-22 |
Methods of treatment involving the protease for activating clotting factor VII
Grant 7,879,803 - Romisch , et al. February 1, 2 | 2011-02-01 |
Antibodies for specifically detecting pathogenic prions of human origin, and detection methods carried out using these antibodies
Grant 7,863,006 - Vey , et al. January 4, 2 | 2011-01-04 |
Mutants of the factor VII-activating protease and detection methods using specific antibodies
Grant 7,863,009 - Roemisch , et al. January 4, 2 | 2011-01-04 |
Inhibitory monoclonal antibody against blood clotting factor VII-activating protease
Grant 7,829,095 - Roemisch , et al. November 9, 2 | 2010-11-09 |
Marburg I mutant of factor VII activating protease (FSAP) as risk factor for arterial thrombosis and methods of detecting FSAP and FSAP mutations
Grant 7,803,569 - Kiechl , et al. September 28, 2 | 2010-09-28 |
Concentrate of a factor VIII:C-containing von Willebrand factor and the process relating thereto
Grant 7,625,866 - Kumpe , et al. December 1, 2 | 2009-12-01 |
Fibrin adhesive granulate and method for its preparation
Grant 7,572,769 - Rapp , et al. August 11, 2 | 2009-08-11 |
Mutants of the factor VII-activating protease and detection methods using specific antibodies
App 20090162871 - Roemisch; Juergen ; et al. | 2009-06-25 |
Fibrinogen purification
Grant 7,550,567 - Metzner , et al. June 23, 2 | 2009-06-23 |
Modified Vitamin K Dependent Polypeptides
App 20090130060 - Weimer; Thomas ; et al. | 2009-05-21 |
Procedure for the determination of the activity of the protease which activates factor VII from protein solutions
App 20090087864 - Roemisch; Juergen ; et al. | 2009-04-02 |
Fluid transfer device
Grant 7,491,197 - Jansen , et al. February 17, 2 | 2009-02-17 |
Pharmaceutical preparation with RNA as hemostasis cofactor
App 20080317735 - Preissner; Klaus ; et al. | 2008-12-25 |
Mutants of the factor VII-activating protease and detection methods using specific antibodies
Grant 7,442,514 - Roemisch , et al. October 28, 2 | 2008-10-28 |
Protease for activating clotting factor VII
App 20080175878 - Romisch; Jurgen ; et al. | 2008-07-24 |
Thrombin preparations and process for their production
Grant 7,351,561 - Metzner , et al. April 1, 2 | 2008-04-01 |
Use of plasma proteins concentrates containing VWF with a high proportion of high molecular weight multimers
Grant 7,335,634 - Walter , et al. February 26, 2 | 2008-02-26 |
| 